Prothena Corp Public (PRTA) Change in Receivables (2014 - 2024)
Prothena Corp Public's (PRTA) quarterly Change in Receivables came in at -$5.2 million in Q1 2024, down 211.31% quarter-over-quarter from $4.6 million in Q3 2023.
Prothena Corp Public (PRTA) Change in Receivables (2014 - 2024) Analysis & Trends
Prothena Corp Public's Change in Receivables history runs 10 years deep, the most recent figure standing at -$5.2 million for Q1 2024.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to -$5.2 million in Q1 2024; TTM through Dec 2024 was -$5.2 million, a 200.0% decrease from a year earlier, with the FY2024 full-year figure at -$5.2 million, down 200.0% from the prior year.
- Change in Receivables retreated to -$5.2 million in Q1 2024 per PRTA's latest filing, from $4.6 million in the prior quarter.
- Across five years, Change in Receivables topped out at $4.6 million in Q3 2023 and bottomed at -$5.2 million in Q1 2024.
- The 4-year median for Change in Receivables is -$7000.0 (2020), against an average of -$6181.8.
- Biggest YoY gain for Change in Receivables was 2020.0% in 2020; the steepest drop was 1585.71% in 2020.
- Year by year, Change in Receivables stood at -$7000.0 in 2020, then plunged by 1028.57% to -$79000.0 in 2021, then soared by 5967.09% to $4.6 million in 2023, then plunged by 211.31% to -$5.2 million in 2024.
- Per Business Quant, the three latest PRTA Change in Receivables figures stand at -$5.2 million (Q1 2024), $4.6 million (Q3 2023), and $524000.0 (Q2 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -5.16 Mn |
| Mar 31, 2024 | -5.16 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Jun 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 524,000.00 |
| Dec 31, 2021 | -79,000.00 |
| Dec 31, 2021 | -79,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | -14,000.00 |
| Mar 31, 2021 | -14,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Sep 30, 2020 | -34,000.00 |
| Sep 30, 2020 | -34,000.00 |
| Jun 30, 2020 | -118,000.00 |
| Jun 30, 2020 | -118,000.00 |